SCHEMBL3410954

SCHEMBL3410954

O=C(O)CC(=O)COc1c(F)c(F)cc(F)c1F

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 2/20 0.48
▸ KDM4E B2RXH2 2/20 0.48
▸ ALDH1A1 P00352 1/20 0.48
▸ HTT P42858 1/20 0.48
▸ MAPK1 P28482 1/20 0.47
▸ CASP3 P42574 11/20 0.43
▸ CASP6 P55212 4/20 0.43
▸ CASP8 Q14790 4/20 0.43
▸ CASP7 P55210 1/20 0.43
▸ TSHR P16473 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ CTSV O60911 1/20 0.40
▸ CTSL P07711 1/20 0.40
▸ CTSB P07858 1/20 0.40
▸ CTSH P09668 1/20 0.40
▸ CTSS P25774 1/20 0.40
▸ CTSK P43235 1/20 0.40
▸ CTSF Q9UBX1 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3216951 0.87 MAPT (0.50) MAPTKDM4EALDH1A1HTTMAPK1
SCHEMBL13382341 0.85 TSHR (0.56) MAPTKDM4EALDH1A1HTTMAPK1
SCHEMBL29503795 0.84 MAPT (0.43) MAPTKDM4EALDH1A1HTTMAPK1
SCHEMBL12745899 0.81 KDM4E (0.48) MAPTKDM4EALDH1A1HTTMAPK1
SCHEMBL22308325 0.80 MAPT (0.49) MAPTKDM4EALDH1A1HTTMAPK1
SCHEMBL18215408 0.79 KDM4E (0.49) MAPTKDM4EALDH1A1HTTMAPK1
SCHEMBL956347 0.79 KDM4E (0.46) MAPTKDM4EALDH1A1HTTMAPK1
SCHEMBL4289806 0.77 MAPT (0.43) MAPTKDM4EALDH1A1HTTMAPK1
SCHEMBL22753433 0.77 KDM4E (0.47) MAPTKDM4EALDH1A1HTTMAPK1
SCHEMBL18678090 0.77 KDM4E (0.44) MAPTKDM4EALDH1A1HTTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2257552-A1 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF CXCR2 Novartis AG (CH) 2010-12-08 — — EP disclosed
WO-2009106539-A1 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF CXCR2 NOVARTIS AG (CH) 2009-09-03 — — WO disclosed
Send feedback